SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011667
Filing Date
2017-11-09
Accepted
2017-11-09 16:04:23
Documents
62
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0917_delmarpharma.htm 10-Q 644821
2 CERTIFICATION f10q0917ex31-1_delmarpharma.htm EX-31.1 14431
3 CERTIFICATION f10q0917ex31-2_delmarpharma.htm EX-31.2 13855
4 CERTIFICATION f10q0917ex32-1_delmarpharma.htm EX-32.1 4840
5 CERTIFICATION f10q0917ex32-2_delmarpharma.htm EX-32.2 4451
6 GRAPHIC image_001.jpg GRAPHIC 13637
7 GRAPHIC image_002.jpg GRAPHIC 31079
8 GRAPHIC image_003.jpg GRAPHIC 22869
9 GRAPHIC image_004.jpg GRAPHIC 8261
10 GRAPHIC image_005.jpg GRAPHIC 9651
11 GRAPHIC image_006.jpg GRAPHIC 14150
12 GRAPHIC image_007.jpg GRAPHIC 23730
  Complete submission text file 0001213900-17-011667.txt   3901306

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE dmpi-20170930.xml EX-101.INS 584942
14 XBRL SCHEMA FILE dmpi-20170930.xsd EX-101.SCH 52706
15 XBRL CALCULATION FILE dmpi-20170930_cal.xml EX-101.CAL 24954
16 XBRL DEFINITION FILE dmpi-20170930_def.xml EX-101.DEF 227271
17 XBRL LABEL FILE dmpi-20170930_lab.xml EX-101.LAB 423145
18 XBRL PRESENTATION FILE dmpi-20170930_pre.xml EX-101.PRE 304546
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 171190722
SIC: 2834 Pharmaceutical Preparations